Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.147NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
P.1.6 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.6 (Gamma)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
P.1.6 (Gamma)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
P.1.6 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.6 (Gamma)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
P.1.5 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.5 (Gamma)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
P.1.5 (Gamma)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
P.1.5 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.5 (Gamma)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
P.1.4 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.4 (Gamma)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
P.1.4 (Gamma)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
P.1.4 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.4 (Gamma)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.420EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.420NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.420NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-3342.44Germany
B.1.420NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.420NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.2.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.12NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.2.12NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.2.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.12NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.39.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.39.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BF.39.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BF.39.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.39.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EK.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EK.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EK.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EK.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.233EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.233NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.233NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.233NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.233NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-16998.3Japan
XBB.1.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.24NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.24NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.1.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.24NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.320EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.320NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.320NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.320NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used